Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 33, 2008, Pages 11772-11777

  Yamaoka, Toshimitsu ^a   Yan, Fang ^a   Cao, Hanwei ^a   Hobbs, Stuart S ^a   Dise, Rebecca S ^a   Tong, Wei ^a   Polk, D Brent ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN KINASE B; STEROID RECEPTOR COACTIVATOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; WILD TYPE;

ANIMALS; APOPTOSIS; ENZYME ACTIVATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; INTESTINES; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SRC-FAMILY KINASES; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 50149105621     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0801463105     Document Type: Article

References (44)

1. Carswell EA, et al. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3670.
2. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70.
3. Micheau O, Tschopp J (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181-190.
4. Yan F, John SK, Polk DB (2001) Kinase suppressor of Ras determines survival of intestinal cells exposed to tumor necrosis factor. Cancer Res 61:8668-8675.
5. Yan F, et al. (2004) Kinase suppressor of Ras protects intestinal epithelium from cytokine-mediated apoptosis during inflammation. J Clin Invest 114:1272-1280.
6. Yan F, Polk DB (2002) Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277:50959-50965.
7. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239-252.
8. Xia Z, Dickens M, Rainegeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 Map kinases on apoptosis. Science 270:1326-1331.
9. Citri A, Yarden Y (2006) EGF-ERBB signalling: Towards the systems level. Nat Rev Mol Cell Biol 7:505-516.
10. Citri A, Skaria KB, Yarden Y (2003) The deaf and the dumb: The biology of ErbB-2 and ErbB-3. Exp Cell Res 284:54-65.
11. Carpenter G (2003) ErbB-4: Mechanism of action and biology. Exp Cell Res 284:66-77.
12. Zwick E, Hackel PO, Prenzel N, Ullrich A (1999) The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol Sci 20:408-412.
13. Argast GM, Campbell JS, Brooling JT, Fausto N (2004) Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J Biol Chem 279:34530-34536.
14. Chen WN, et al. (2004) Induced autocrine signaling through the epidermal growth factor receptor contributes to the response of mammary epithelial cells to tumor necrosis factor alpha. J Biol Chem 279:18488-18496.
15. Itoh Y, et al. (2005) IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. Cytokine 29:275-282.
16. Tanida S, et al. (2004) The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells. Gastroenterology 127:559-569.
17. Fischer OM, Hart S, Gschwind A, Ullrich A (2003) EGFR signal transactivation in cancer cells. Biochem Soc Trans 31:1203-1208.
18. Tice DA, Biscardi JS, Nickles AL, Parsons SJ (1999) Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci USA 96:1415-1420.
19. Szlosarek P, Charles KA, Balkwill FR (2006) Tumour necrosis factor-alpha as a tumour promoter. Eur J Cancer 42:745-750.
20. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137.
21. Garside P, Bunce C, Tomlinson RC, Nichols BL, Mowat AM (1993) Analysis of enteropathy induced by tumour necrosis factor α. Cytokine 5:24-30.
22. Garside P, Mowat AM (1993) Natural killer cells and tumour necrosis factor-α-mediated enteropathy in mice. Immunology 78:335-337.
23. Kiesslich R, et al. (2007) Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy. Gastroenterology 133:1769-1778.
24. Frey MR, Golovin A, Polk DB (2004) Epidermal growth factor-stimulated intestinal epithelial cell migration requires Src family kinase-dependent p38 MAPK signaling. J Biol Chem 279:44513-44521.
25. Kaiser GC, Polk DB (1997) Tumor necrosis factor α regulates proliferation in a mouse intestinal cell line. Gastroenterology 112:1231-1240.
26. Kaiser GC, Yan F, Polk DB (1999) Conversion of TNFα from antiproliferative to proliferative ligand in mouse intestinal epithelial cells by regulating mitogen-activated protein kinase. Exp Cell Res 249:349-358.
27. Shrader M, et al. (2007) Gefitinib reverses TRAIL resistance inhumanbladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression. Cancer Res 67:1430-1435.
28. Singhirunnusorn P, et al. (2007) Transient suppression of ligand-mediated activation of epidermal growth factor receptor by tumor necrosis factor-alpha through the TAK1-p38 signaling pathway. J Biol Chem 282:12698-12706.
29. Ueno Y, et al. (2005) Selective inhibition of TNF-alpha-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib. Br J Cancer 92:1690-1695.
30. Breese EJ, et al. (1994) Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106:1455-1466.
31. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM (1998) Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 66:5964-5971.
32. Malecka-Panas E, et al. (1997) Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer. Hepatogastroenterology 44:435-440.
33. Graus-Porta D, Beerli RR, Daly JM, Hynes NE (1997) ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16:1647-1655.
34. Lenferink AE, et al. (1998) Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers. EMBO J 17:3385-3397.
35. Olayioye MA, et al. (1998) ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner. Mol Cell Biol 18:5042-5051.
36. Worthylake R, Opresko LK, Wiley HS (1999) ErbB-2 amplification inhibits downregulation and induces constitutive activation of both ErbB-2 and epidermal growth factor receptors. J Biol Chem 274:8865-8874.
37. Qian X, LeVea CM, Freeman JK, Dougall WC, Greene MI (1994) Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: A mechanism of interreceptor kinase activation and transphosphorylation. Proc Natl Acad Sci USA 91:1500-1504.
38. Worthylake R, Wiley HS (1997) Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu. J Biol Chem 272:8594-8601.
39. Popivanova BK, et al. (2008) Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 118:560-570.
40. He XC, et al. (2007) PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet 39:189-198.
41. Whitehead RH, VanEeden PE, Noble MD, Ataliotis P, Jat PS (1993) Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc Natl Acad Sci USA 90:587-591.
42. Dise RS, Frey MR, Whitehead RH, Polk DB (2008) Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 294:G276-G285.
43. Luetteke NC, et al. (1994) The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 8:399-413.
44. Polk DB (1994) Ontogenic regulation of PLCγ1 activity and expression in the rat small intestine. Gastroenterology 107:109-116.